BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Welcome to the 3rd ADC Toxicity Summit\n\n"Toxicity is the kil
 ler of ADCs" and remains the primary challenge limiting ADC success in th
 e clinic. From unpredictable off-target effects to non-translating toxici
 ty profiles and dose-limiting toxicities\, the industry must address key 
 hurdles in preclinical models\, patient selection\, ADC design\, and cros
 s-disciplinary communication to accelerate the next wave of safer\, more 
 effective ADCs.\n\nThe 3rd ADC Toxicity Summit is the only industry-led e
 vent bringing together toxicology\, pharmacology\, translational science\
 , and clinical development experts to accelerate bench-to-bedside-to-benc
 h innovation by preventing\, predicting\, and mitigating toxicities to en
 hance ADC safety and clinical translation.\n\nWith insights from influent
 ial leaders such as AbbVie\, AstraZeneca\, Daiichi Sankyo\, Genentech\, I
 ksuda\, JandJ\, MacroGenics and more\, this is your opportunity for in-de
 pth discussions and world class presentations on maximizing the translati
 onal relevance of in vivo and in vitro studies\, mitigating toxicities to
  extend clinical dose escalations\, optimizing dosing regimens\, navigati
 ng regulatory expectations for toxicity models and more...\n\nURLs:Websit
 e:&nbsp\;https://go.evvnt.com/3101075-0?pid=185Tickets:&nbsp\;https://go.
 evvnt.com/3101075-2?pid=185Brochure:&nbsp\;https://go.evvnt.com/3101075-3
 ?pid=185\n\nPrices:Drug Developer Pricing - 3 Day Pass (Conference + Work
 shop Day): USD 4197.00\,Drug Developer Pricing - 2 Day Pass (Conference O
 nly): USD 2999.00\,Academic Pricing - 3 Day Pass (Conference + Workshop D
 ay): USD 3597.00\,Academic Pricing - 2 Day Pass (Conference Only): USD 25
 99.00\,Service Provider Pricing - 3 Day Pass (Conference + Workshop Day):
  USD 5097.00\,Service Provider Pricing - 2 Day Pass (Conference Only): US
 D 3699.00\n\nSpeakers:&nbsp\;Andy Judd\, Medicinal Chemist\, Abbvie\, Ann
 a Engstrom\, Senior Principal Scientist and Toxicologist Safety Assessmen
 t\, Genentech\, Carole Harbison\, Associate Scientific Fellow\, Pathology
 \, Takeda Pharmaceutical\, Grace Lytle\, Executive Director\, Ocular Medi
 cal\, AbbVie\, Jennifer Brown\, Senior Director of Toxicology\, MacroGeni
 cs\, John Kwon\, Associate Director\, AstraZeneca\, Julia Kristensson\, A
 ssociate Director\, Bicycle Therapeutics\, Kristin Decker\, Associate Dir
 ector Pharmacology and Toxicology\, Heidelberg Pharma\, Megan Terral\, Di
 rector of Scientific Operations\, AxoSim\, Neel Pasricha\, Assistant Prof
 essor of Ophthalmology\, University of Califorina\, San Francisco\, Nicol
 as Quesnot\, Senior Scientist\, Preclinical Safety\, Debiopharm\, Paolo T
 arantino\, Clinical Research Fellow\, Dana-Farber Cancer Institute\, Raym
 ond Evers\, Senior Director\, Global Translational ADME\, Translational P
 K/PD and Investigative Toxicology\, Johnson and Johnson\, Robert Lutz\, C
 hief Scientific Officer\, Iksuda Therapeutics\, Ronnie Yeager\, Project D
 irector\, Emerging Therapeutic Platforms Beacon\, Abbvie\, Sonia Jain\, R
 esearch Associate Radiation Oncology\, Mayo Clinic\, Steve Everett\, Chie
 f Executive Officer\, MaveriX Oncology\, Yu-Tzu Tai\, Associate Director\
 , Oxford BioTherapeutics\, Zenta Tsuchihashi\, Senior Director\, Clinical
  Safety and Pharmacovigilance\, Daiichi Sankyo\n\nCategory:&nbsp\;Confere
 nces | Health\n\nDate and Time:&nbsp\;8th July 2025 at 8:00 am to 10th Ju
 ly 2025 at 3:15 pm\n\nVenue details:&nbsp\;Hilton Boston Back Bay\, 40 Da
 lton Street\, Boston\, Massachusetts\, 02115\, United States\n
DTEND:20250710T151500
DTSTAMP:20260512T223118Z
DTSTART:20250708T080000
LOCATION:Hilton Boston Back Bay\, 40\, Dalton Street\, Boston\, Massachuse
 tts\, 02115\,
SEQUENCE:0
SUMMARY:Welcome to the 3rd ADC Toxicity Summit\n"Toxicity is the killer of
  ADCs" and remains the primary challenge limiting ADC success in the clin
 ic. From...
UID:145e2e4c-4b6d-4344-91b6-ad113e1fb12e
END:VEVENT
END:VCALENDAR